Over Elekta Veenendaal
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. The advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. The treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Elekta is headquartered in Stockholm, Sweden.
In Veenendaal, Elekta develops and produces the brachytherapy solutions and equipment. Brachytherapy is a type of “internal” radiation therapy used to treat cancer. It places radioactive sources inside the patient to kill cancer cells and shrink tumors (for example cervical cancer, prostate cancer, etc.). This allows your doctor to use a higher total dose of radiation to treat a smaller area in less time and limit damage on healthy tissue and organs. An afterloader and applicators are used for treatment/positioning the source.